News

March 13, 2015

Dr. Monica Shah Publishes on High Priority Research Including REPRIEVE Trial

Please see attached link to article “Stimulating High Impact HIV-Related Cardiovascular Research: Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease” by Dr. Monica Shah published in the February 24, 2015 issue of the Journal of the American College of Cardiology.
March 10, 2015

Dr. Steven Grinspoon is Interviewed about REPRIEVE

At the 2015 Conference on Retroviruses and Opportunistic Infections (CROI Conference) in Seattle, Washington, Dr. Steven Grinspoon, Co-PI of the REPRIEVE trial, is interviewed on the topic of his plenary presentation: “Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action”.
October 27, 2014

MGH: Can statin treatment cut cardiovascular risk in HIV-infected patients?

BOSTON – A nationwide study based at Massachusetts General Hospital (MGH) will investigate, for the first time, whether treatment with a statin drug can reduce the elevated risk of cardiovascular disease in individuals infected with the human immunodeficiency virus (HIV).
October 22, 2014

NY Times: “Heart Trouble Early and Often in H.I.V. Patients”

He was 29 when he began antiretroviral therapy.He was 43 when he had a heart attack.“I felt fluttery,” he said. “Weird and fluttery. It went away. I ignored it. A week later, it came back, and this time I felt something in my arm too. I was too stupid to call an ambulance. I got in a cab and went to the hospital.”
March 13, 2015

Dr. Monica Shah Publishes on High Priority Research Including REPRIEVE Trial

Please see attached link to article “Stimulating High Impact HIV-Related Cardiovascular Research: Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease” by Dr. Monica Shah published in the February 24, 2015 issue of the Journal of the American College of Cardiology.
March 10, 2015

Dr. Steven Grinspoon is Interviewed about REPRIEVE

At the 2015 Conference on Retroviruses and Opportunistic Infections (CROI Conference) in Seattle, Washington, Dr. Steven Grinspoon, Co-PI of the REPRIEVE trial, is interviewed on the topic of his plenary presentation: “Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action”.
October 27, 2014

MGH: Can statin treatment cut cardiovascular risk in HIV-infected patients?

BOSTON – A nationwide study based at Massachusetts General Hospital (MGH) will investigate, for the first time, whether treatment with a statin drug can reduce the elevated risk of cardiovascular disease in individuals infected with the human immunodeficiency virus (HIV).
October 22, 2014

NY Times: “Heart Trouble Early and Often in H.I.V. Patients”

He was 29 when he began antiretroviral therapy.He was 43 when he had a heart attack.“I felt fluttery,” he said. “Weird and fluttery. It went away. I ignored it. A week later, it came back, and this time I felt something in my arm too. I was too stupid to call an ambulance. I got in a cab and went to the hospital.”